WHO Recommends Merck COVID Pill for non-severe, at-risk patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalization, such as older people or the unvaccinated. The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after Covid-19…
Asharq Al-Awsat ·